Media kits

Information about Targeted Drug Delivery treatment options.

Information about Medtronic spinal cord stimulation and AdaptiveStim™ Technology.

Information about sacral neuromodulation, a proven treatment option for bladder control and bowel control.

Information about the Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart standalone CGM system to help people with diabetes using multiple daily injections (MDI) stay ahead of high and low glucose events.

Information about the MiniMed® 770G system which features smartphone connectivity and an expanded age indication down to the age of 2 years old.

Information about the MiniMed™ 780G system, a next generation closed loop insulin pump system for the treatment of type 1 diabetes.

Information about the MiniMed® 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.

Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.

Information about the Melody® Transcatheter Pulmonary Valve, which offers a non-surgical valve replacement option for congenital heart disease patients. Melody is the first transcatheter heart valve to receive FDA approval and represents a significant development in the treatment of congenital heart disease.

To learn more, please visit Melody-TPV.com.

Information about heart valve disease and heart valve replacement.

Information about coronary artery disease (CAD) and its minimally invasive treatment with the Resolute Drug-Eluting Stent (DES) Platform.

Information about a new approach to traditional bypass surgery.

Sudden cardiac arrest (SCA) is a sudden, abrupt loss of heart function. Most SCA episodes are caused by the rapid and/or chaotic activity of the heart known as ventricular tachycardia (VT) or ventricular fibrillation (VF). These are abnormalities of the heart’s electrical conduction system. SCA claims the lives of nearly 1,000 Americans each day – many of these deaths are preventable.

Information about the Reveal LINQ II ICM designed to give physicians valuable insights that could help identify the cause of unexplained fainting.

Information about the Reveal LINQ II ICM – a miniaturized implantable cardiac monitor designed to help physicians quickly and accurately diagnose irregular heartbeats.

Information about devices implanted in the chest to treat hearts that tend to beat too slowly to support the needs of the human circulatory system.

The Medtronic CareLink Network is the industry's leading and longest-running remote monitoring system. CareLink provides health care providers and patients the convenience of telemedicine by remotely monitoring patients implanted with Medtronic cardiac devices and providing comprehensive data received from the implanted cardiac devices to their physicians.

Information about the Medtronic HeartWare™ HVAD™ System, which is a left ventricular assist device (LVAD) that helps the heart pump and increases the amount of blood that circulates through the body.

Information about devices surgically implanted in the chest to continuously monitor hearts that tend to beat dangerously fast and deliver corrective electrical impulses when required. An ICD is often known as 'an emergency room in your chest.'

Information about devices used for Cardiac Resynchronization Therapy.

Information about the minimally invasive procedure to treat medication-resistant paroxysmal atrial fibrillation (PAF) using the Arctic Front Advance™ Cardiac Cryoablation System.

Information about the minimally invasive procedure to treat peripheral artery disease (PAD) using IN.PACT Admiral drug-coated balloon.

Information about thoracic aortic aneurysms (TAAs) and their minimally invasive treatment with the Valiant Captivia Thoracic Stent Graft System.

Information about abdominal aortic aneurysms (AAAs) and their minimally invasive treatment with the Endurant AAA Stent Graft System.

Information about Medtronic’s operations, mission and vision.